Skip to main content

Study

Light Therapy May Boost Memory in Seniors with Dementia

Near-infrared light therapy improved cognitive function in seniors with mild to moderate dementia after 12 weeks of treatment.

Memory SupportBrain HealthHealthy AgingNeurological Health
Study Credibility: Low2.8/10Early findingsNot enough evidence yetTalk with your clinician
PublishedFeb 2017JournalPhotomedicine and Laser SurgeryDesignCase ReportLast reviewedJun 2026
Email this

Summary

In plain language

Researchers have found that using near-infrared light therapy, also known as photobiomodulation, can significantly enhance cognitive function in seniors with mild to moderately severe dementia. In a small study, five participants received this therapy using a combination of transcranial and intranasal devices. After 12 weeks, participants showed notable improvements in memory and cognitive tests, with better sleep and reduced anxiety also reported. Importantly, no negative side effects were observed. This study suggests that light therapy could be a promising, non-invasive treatment option for dementia, though more extensive research is needed. Seniors interested in this therapy should consult with their healthcare providers for personalized advice.

Details

Use the full description to understand the study design, methods, and the limits of the findings.

This study explored the effects of photobiomodulation, a type of light therapy, on cognitive function in seniors with dementia. Researchers treated five patients with mild to moderate dementia using near-infrared light therapy devices for 12 weeks, both in-clinic and at home.

  • The study showed significant improvements in cognitive test scores, including the Mini-Mental State Exam and Alzheimer's Disease Assessment Scale.

  • Participants also experienced better sleep and reduced anxiety, with no adverse side effects.

  • However, cognitive improvements diminished during a follow-up period without treatment, indicating the need for ongoing therapy.

This therapy could be an exciting option for seniors seeking non-drug interventions for dementia, but it's essential to discuss potential treatments with healthcare professionals.

Research Quality Score

Scored June 8, 2026 using rubric v9_2026-04-08.

Assessment

The study is a case series, which inherently limits its methodological rigor and evidence level. It lacks controls and statistical analysis, making it less reliable. However, it is relevant to seniors due to its focus on dementia. The journal is reputable, but not top-tier.

Category Breakdown

CategoryScoreRating
Study design3.3/10
Bias control0.0/10
Statistical methods0.0/10
Reporting completeness2.5/10
Conflicts & funding5.0/10
Replication0.0/10
Relevance to chosen population10.0/10
Journal Reliability5.0/10

Additional Notes

The study's design limits its applicability for drawing strong conclusions. Further research with more rigorous methods is needed.

Take the next step

Build a personalized plan using research-backed studies, conditions, and treatments.